Binding of tolbutamide to glycated human serum albumin
Authors:
- Jeanethe AnguizolaJAJeanethe Anguizola
- David S. HageDHDavid S. Hage
- 1 January 2011
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 54 (2) , 426-432
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01 DK069629)
- National Institutes of Health (RR015468-01)
This publication has 26 references indexed in Scilit:
- The effects of glycation on the binding of human serum albumin to warfarin and l-tryptophanJournal of Pharmaceutical and Biomedical Analysis, 2010
- Characterization of the binding of sulfonylurea drugs to HSA by high-performance affinity chromatographyJournal of Chromatography B, 2010
- Evaluation of indole‐based probes for high‐throughput screening of drug binding to human serum albumin: Analysis by high‐performance affinity chromatographyJournal of Separation Science, 2009
- Evaluation of alternatives to warfarin as probes for Sudlow site I of human serum albuminJournal of Chromatography A, 2009
- Stability of warfarin solutions for drug–protein binding measurements: Spectroscopic and chromatographic studiesJournal of Pharmaceutical and Biomedical Analysis, 2006
- Drug binding to human serum albumin: Abridged review of results obtained with high‐performance liquid chromatography and circular dichroismChirality, 2006
- The extraordinary ligand binding properties of human serum albuminIUBMB Life, 2005
- Crystal Structure Analysis of Warfarin Binding to Human Serum AlbuminJournal of Biological Chemistry, 2001
- Five recombinant fragments of human serum albumin—tools for the characterization of the warfarin binding siteProtein Science, 2000
- Localization of Tolbutamide Binding Sites on Human Serum Albumin Using Titration Calorimetry and Heteronuclear 2-D NMRBiochemistry, 1995